Planta Med 1985; 51(1): 6-9
DOI: 10.1055/s-2007-969378
Research Articles

© Georg Thieme Verlag Stuttgart · New York

Spasmolytische Wirkung des Isoasaronfreien Kalmus1

Konstantin Keller2 , Karl Peter Odenthal3 , Elke Leng-Peschlow3
  • 2Retzgrubenweg 12, D-5500 Trier, W. Germany
  • 3Dr. Madaus & Co., Abt. Pharmakologie, D-5000 Köln 91, W. Germany
1 Herrn Professor Dr. Dr. h. c. mult. Egon Stahl zum 60. Geburtstag gewidmet
Further Information

Publication History

1984

1984

Publication Date:
26 February 2007 (online)

Abstract

Acorus calamus yields different drug types with varying content of β-asarone, a substance which proved to be carcinogetic in rats. We tested essential oils with different β-asarone content for their activity against histatnine-spasms in the isolated guinea pig ileum. At a dose level of 10 µg/cm3, the β-asarone-free oil (type I) had a pronounced, spasmolytic activity which was comparable to that of the antihistaminic drug pyrilaminemaleate used as a standard antagonist (4 µg/cm3. Each of these drugs changed the EC50 for histamine from 29 µg/cm3 to 118 µg/cm3 approximately. At a dose level of 10 µg/cm3 the β-asarone-rich oil (type IV) showed no spasmolytic activity at all. The essential oil of the european calamus with low content of β-asarone (type II) had also a good spasmolytic effect, however inferior to that of the β-asarone-free oil, so that the above cited decrease of the EC50 value of histamine could be seen in a concentration of 32 µg/cm3. For this reasons and for better drug-safety, only the rhizomas of the β-asarone-free diploid or of the triploid calamus with low content of β-asarone should be used.

    >